E-LIB Suche - Ergebnisse für: Duncombe, Andrew S

1

The JAK2V617F mutation and the role of therapeutic agents i..:

Orbell, Lai Yee ; Abutheraa, Nouf ; Duncombe, Andrew S...
eJHaem. 4 (2023) 4 - p. 1071-1080 , 2023

Link: https://doi.org/10.1002/..

2

A hyperinflammation clinical risk tool, HI5-NEWS2, stratifi..:

Ardern-Jones, Michael R. ; Phan, Hang T. T. ; Borca, Florina...
PLOS ONE. 18 (2023) 1 - p. e0280079 , 2023

Link: https://doi.org/10.1371/..

3

Glioblastoma, IDH-wildtype: A New Association with IgM Para..:

Lewis, Dana M. ; Colchester, Nancy T.H. ; Allen, David...
Case Reports in Neurology. 14 (2022) 1 - p. 213-222 , 2022

Link: https://doi.org/10.1159/..

4

Secondary haemophagocytic lymphohistiocytosis in hospitalis..:

Ardern-Jones, Michael R ; Stammers, Matt ; Phan, Hang TT...
Clinical Medicine. 21 (2021) 5 - p. e543-e547 , 2021

Link: https://doi.org/10.7861/..

5

Circulating promastocytes and atypical mast cells in system..:

Altohami, Mohammed O. A. ; Lewis, Dana ; Duncombe, Andrew S.
eJHaem. 2 (2021) 3 - p. 663-664 , 2021

Link: https://doi.org/10.1002/..

6

Modifiable Lifestyle and Medical Risk Factors Associated Wi..:

Duncombe, Andrew S. ; Anderson, Lesley A. ; James, Glen...
HemaSphere. 4 (2020) 1 - p. , 2020

Link: https://doi.org/10.1097/..

7

Chemoimmunotherapy with rituximab, cyclophosphamide and pre..:

Colchester, Nancy T.H. ; Allen, David ; Katifi, Haider A....
Haematologica. 106 (2020) 1 - p. 302-305 , 2020

Link: https://doi.org/10.3324/..

8

Genome instability is a consequence of transcription defici..:

Tummala, Hemanth ; Dokal, Arran D. ; Walne, Amanda...
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 30 - p. 7777-7782 , 2018

Link: https://www.jstor.org/st..

9

Genome instability is a consequence of transcription defici..:

Tummala, Hemanth ; Dokal, Arran D. ; Walne, Amanda...
Proceedings of the National Academy of Sciences. 115 (2018) 30 - p. 7777-7782 , 2018

Link: https://doi.org/10.1073/..

10

Recurrent activating STAT5B N642H mutation in myeloid neopl..:

Cross, Nicholas C. P. ; Hoade, Yvette ; Tapper, William J....
Leukemia. 33 (2018) 2 - p. 415-425 , 2018

Link: https://doi.org/10.1038/..

11

The MOSAICC study: Assessing feasibility for biological sam..:

James, Glen ; McMullin, Mary Frances ; Duncombe, Andrew S..
Annals of Human Genetics. 82 (2017) 2 - p. 114-118 , 2017

Link: https://doi.org/10.1111/..

12

Patient perspectives of a diagnosis of myeloproliferative n..:

McMullin, Mary Frances ; James, Glen ; Duncombe, Andrew S....
Experimental Hematology & Oncology. 5 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

13

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predis..:

Tapper, William ; Jones, Amy V. ; Kralovics, Robert...
Nature Communications. 6 (2015) 1 - p. , 2015

Link: https://doi.org/10.1038/..

14

Myeloproliferative neoplasm patient symptom burden and qual..:

Anderson, Lesley A. ; James, Glen ; Duncombe, Andrew S....
American Journal of Hematology. 90 (2015) 10 - p. 864-870 , 2015

Link: https://doi.org/10.1002/..

15

Use of JAK inhibitors in the management of myelofibrosis: a..:

Reilly, John T. ; McMullin, Mary Frances ; Beer, Philip A....
British Journal of Haematology. 167 (2014) 3 - p. 418-420 , 2014

Link: https://doi.org/10.1111/..